The Use of Ferritin to Identify Critically Ill Patients with Secondary Hemophagocytic Lymphohistiocytosis

Critical Care Medicine

Volumn 44, Issue 11, 2016, Pages e1045-e1053

  Grangé, Steven ^a   Buchonnet, Gérard ^a   Besnier, Emmanuel ^a   Artaud Macari, Elise ^a   Beduneau, Gaetan ^a   Carpentier, Dorothée ^a   Dehay, Julien ^a   Girault, Christophe ^a   Marchalot, Antoine ^a   Guerrot, Dominique ^a   Tamion, Fabienne ^a  

^a ROUEN UNIVERSITY HOSPITAL   (France)

Author keywords

ferritin; hemophagocytic lymphohistiocytosis; hemophagocytosis; intensive care unit; thrombocytopenia

Indexed keywords

BILIRUBIN; FERRITIN; FIBRINOGEN; LACTATE DEHYDROGENASE; VASOACTIVE AGENT; BIOLOGICAL MARKER;

ADULT; AGED; ARTICLE; BILIRUBIN BLOOD LEVEL; BONE MARROW EXAMINATION; CELL COUNT; CONTROLLED STUDY; CRITICALLY ILL PATIENT; CYTOPENIA; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; ERYTHROPHAGOCYTOSIS; ESCHERICHIA COLI INFECTION; FEMALE; FERRITIN BLOOD LEVEL; HEMODYNAMICS; HEMOPHAGOCYTIC SYNDROME; HOSPITAL ADMISSION; HUMAN; HUMAN CELL; INTENSIVE CARE UNIT; LACTATE BLOOD LEVEL; LACTATE DEHYDROGENASE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MEGAKARYOCYTE; MORTALITY; OBSERVATIONAL STUDY; PANCYTOPENIA; PATIENT ASSESSMENT; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DETERMINATION; REFERENCE VALUE; RETROSPECTIVE STUDY; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SEPSIS; SIMPLIFIED ACUTE PHYSIOLOGY SCORE; SURVIVOR; THROMBOCYTOPENIA; BLOOD; COMPLICATION; CRITICAL ILLNESS; EPIDEMIOLOGY; FRANCE; HOSPITAL MORTALITY; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC; METABOLISM; MIDDLE AGED; MULTIVARIATE ANALYSIS;

AGED; BIOMARKERS; CRITICAL ILLNESS; FEMALE; FERRITINS; FIBRINOGEN; FRANCE; HOSPITAL MORTALITY; HUMANS; INTENSIVE CARE UNITS; L-LACTATE DEHYDROGENASE; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC; MALE; MEGAKARYOCYTES; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SEPSIS; SIMPLIFIED ACUTE PHYSIOLOGY SCORE; THROMBOCYTOPENIA;

EID: 84979009487     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0000000000001878     Document Type: Article

References (39)

1. Janka G, Stadt zur U: Familial and acquired hemophagocytic lymphohistiocytosis. Hematology Am Soc Hematol Educ Program 2005; 82-88
2. Karras A, Hermine O: [Hemophagocytic syndrome]. Rev Med Interne 2002; 23:768-778
3. Fléchaire A, Colle B, Bernard P, et al: [Hemophagocytic syndromes]. Rev Med Interne 1996; 17:157-162
4. Berrady R, Bono W: [Lymphohistiocytic activation syndrome (LHAS)]. Ann Fr Anesth Reanim 2014; 33:26-32
5. Grom AA: Macrophage activation syndrome and reactive hemophagocytic lymphohistiocytosis: The same entities? Curr Opin Rheumatol 2003; 15:587-590
6. Dhote R, Simon J, Papo T, et al: Reactive hemophagocytic syndrome in adult systemic disease: Report of twenty-six cases and literature review. Arthritis Rheum 2003; 49:633-639
7. Rivière S, Galicier L, Coppo P, et al: Reactive hemophagocytic syndrome in adults: A retrospective analysis of 162 patients. Am J Med 2014; 127:1118-1125
8. Kaito K, Kobayashi M, Katayama T, et al: Prognostic factors of hemophagocytic syndrome in adults: Analysis of 34 cases. Eur J Haematol 1997; 59:247-253
9. Créput C, Galicier L, Oksenhendler E, et al: Syndrome d'activation lymphohistiocytaire: Revue de la littérature, implications en réanimation. Réanimation 2005; 14:604-613
10. Gauvin F, Toledano B, Champagne J, et al: Reactive hemophagocytic syndrome presenting as a component of multiple organ dysfunction syndrome. Crit Care Med 2000; 28:3341-3345
11. Rekik R, Morazin F, Lumbroso A, et al: [Reactive haemophagocytic syndrome and multiple organ failure in intensive care unit patients]. Ann Fr Anesth Reanim 2004; 23:1189-1191
12. Okabe T, Shah G, Mendoza V, et al: What intensivists need to know about hemophagocytic syndrome: An underrecognized cause of death in adult intensive care units. J Intensive Care Med 2012; 27:58-64
13. Buyse S, Teixeira L, Galicier L, et al: Critical care management of patients with hemophagocytic lymphohistiocytosis. Intensive Care Med 2010; 36:1695-1702
14. Demirkol D, Yildizdas D, Bayrakci B, et al; Turkish Secondary HLH/MAS Critical Care Study Group: Hyperferritinemia in the critically ill child with secondary hemophagocytic lymphohistiocytosis/sepsis/multiple organ dysfunction syndrome/macrophage activation syndrome: What is the treatment? Crit Care 2012; 16:R52
15. Osugi Y, Hara J, Tagawa S, et al: Cytokine production regulating Th1 and Th2 cytokines in hemophagocytic lymphohistiocytosis. Blood 1997; 89:4100-4103
16. François B, Trimoreau F, Desachy A, et al: [Hemophagocytosis during multiple organ failure: M-CSF overproduction or viral reactivation?]. Ann Fr Anesth Reanim 2001; 20:514-519
17. François B, Trimoreau F, Vignon P, et al: Thrombocytopenia in the sepsis syndrome: Role of hemophagocytosis and macrophage colonystimulating factor. Am J Med 1997; 103:114-120
18. Strauss R, Neureiter D, Westenburger B, et al: Multifactorial risk analysis of bone marrow histiocytic hyperplasia with hemophagocytosis in critically ill medical patients-a postmortem clinicopathologic analysis. Crit Care Med 2004; 32:1316-1321
19. Galicier L: What we should know about hemophagocytic syndrom in the intensive care unit. Réanimation 2013; 23:482-490
20. Castillo L, Carcillo J: Secondary hemophagocytic lymphohistiocytosis and severe sepsis/systemic inflammatory response syndrome/multiorgan dysfunction syndrome/macrophage activation syndrome share common intermediate phenotypes on a spectrum of inflammation. Pediatr Crit Care Med 2009; 10:387-392
21. Nau GJ, Richmond JF, Schlesinger A, et al: Human macrophage activation programs induced by bacterial pathogens. Proc Natl Acad Sci U S A 2002; 99:1503-1508
22. Gonzalez F, Vincent F, Cohen Y: Syndrome d'activation macrophagique d'origine infectieuse: Étiologies et prise en charge. Réanimation 2009; 18:284-290
23. Stéphan F, Thiolière B, Verdy E, et al: Role of hemophagocytic histiocytosis in the etiology of thrombocytopenia in patients with sepsis syndrome or septic shock. Clin Infect Dis 1997; 25:1159-1164
24. Rouphael NG, Talati NJ, Vaughan C, et al: Infections associated with haemophagocytic syndrome. Lancet Infect Dis 2007; 7:814-822
25. Fisman DN: Hemophagocytic syndromes and infection. Emerg Infect Dis 2000; 6:601-608
26. Geerlings SE, Rommes JH, van Toorn DW, et al: Acute folate deficiency in a critically ill patient. Neth J Med 1997; 51:36-38
27. Easton DJ: Severe thrombocytopenia associated with acute folic acid deficiency and severe hemorrhage in two patients. Can Med Assoc J 1984; 130:418-420, 422
28. Schaer DJ, Schaer CA, Schoedon G, et al: Hemophagocytic macrophages constitute a major compartment of heme oxygenase expression in sepsis. Eur J Haematol 2006; 77:432-436
29. M ller HJ, Moestrup SRK, Weis N, et al: Macrophage serum markers in pneumococcal bacteremia: Prediction of survival by soluble CD163. Crit. Care Med. 2006; 34:2561-2566
30. Garcia PC, Longhi F, Branco RG, et al: Ferritin levels in children with severe sepsis and septic shock. Acta Paediatr 2007; 96:1829-1831
31. Allen CE, Yu X, Kozinetz CA, et al: Highly elevated ferritin levels and the diagnosis of hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 2008; 50:1227-1235
32. Lehmberg K, McClain KL, Janka GE, et al: Determination of an appropriate cut-off value for ferritin in the diagnosis of hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 2014; 61:2101-2103
33. Lin TF, Ferlic-Stark LL, Allen CE, et al: Rate of decline of ferritin in patients with hemophagocytic lymphohistiocytosis as a prognostic variable for mortality. Pediatr Blood Cancer 2011; 56:154-155
34. El Khoury N, Lassoued K, Pellé G, et al: [Hemophagocytosis associated with an Escherichia coli sepsis: A case report]. Rev Med Interne 2003; 24:688-691
35. Goo J, Oh YS, Choi EH, et al: A case of hemophagocytic syndrome caused by Pseudomonas aeruginosa. Korean J Dermatol 2006; 44:1430-1433
36. Tisman G, Herbert V: In vitro myelosuppression and immunosuppression by ethanol. J Clin Invest 1973; 52:1410-1414
37. Azfar M, Khan M, Khurshid M: Fibrinogen at admission is an independent predictor of mortality in severe sepsis and septic shock. Critical Care 2014; 18(Suppl 1):P209
38. Quenot JP, Binquet C, Kara F, et al: The epidemiology of septic shock in French intensive care units: The prospective multicenter cohort EPISS study. Crit Care 2013; 17:R65
39. Emmenegger U, Frey U, Reimers A, et al: Hyperferritinemia as indicator for intravenous immunoglobulin treatment in reactive macrophage activation syndromes. Am J Hematol 2001; 68:4-10